BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20681316)

  • 1. [Formula screening and optimizing for the dispersible tablets of breviscapine by orthogonal experiment].
    Ding Y; Huang GH
    Zhong Yao Cai; 2010 Mar; 33(3):455-8. PubMed ID: 20681316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Using mixture design to optimize preparation technology of gankeshuangqing dispersible tablets].
    Zhang F; Han L; Zhang DK; Zhang C; Yang M; Bao AY; Xiao X
    Zhong Yao Cai; 2014 Mar; 37(3):499-503. PubMed ID: 25174118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs.
    Cong W; Shen L; Xu D; Zhao L; Ruan K; Feng Y
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):203-10. PubMed ID: 24061692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the extraction of breviscapine from Erigeron breviscapus with ultrasonic wave technology optimized by central composite design-response surface method].
    He ME; Wang W; Wu LS; Gao YT; Li SY
    Zhong Yao Cai; 2010 Jun; 33(6):984-8. PubMed ID: 21049625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and quality evaluation of fufangxiaoyepipa dispersible tablets].
    Zhao P; Li LL; Yang XY; Jiao HS
    Zhong Yao Cai; 2010 Jun; 33(6):988-90. PubMed ID: 21049626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of Zhongjiefeng dispersible tablets].
    Wu ZF; He W; Li Y
    Zhong Yao Cai; 2008 Oct; 31(10):1557-9. PubMed ID: 19230415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and stability investigation of gastrodin dispersible tablets].
    Xi YW; Huang GH; Li LJ
    Zhong Yao Cai; 2006 Sep; 29(9):970-3. PubMed ID: 17212058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of breviscapine in dogs and rabbits following single intravenous administration].
    Liu Q; Luo G; Wang Y; Ma Y; Zhang R
    Zhong Yao Cai; 2005 Oct; 28(10):913-6. PubMed ID: 16479930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system.
    Ma Y; Li H; Guan S
    Drug Dev Ind Pharm; 2015 Feb; 41(2):177-82. PubMed ID: 25113432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and content determination of Genhuang dispersible tablet herbal formulation.
    Xin RH; Liang G; Zheng JF
    Pak J Pharm Sci; 2017 Mar; 30(2(Suppl.)):655-661. PubMed ID: 28650336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation on the formula of Fuyankang dispersed tablets].
    Tao HM; Wang LS; Heng DY; Xu MC
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(22):1742-4. PubMed ID: 16468368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats.
    Wu YG; Xia LL; Lin H; Zhou D; Qian H; Lin ST
    Planta Med; 2007 May; 73(5):433-8. PubMed ID: 17566145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimize the preparation process of Erigeron breviscapus sustained-release pellets based on artificial neural network and particle swarm optimization algorithm].
    Zhang JX; Chen YZ; Wu ZN; Liao WR
    Zhong Yao Cai; 2012 Jan; 35(1):127-33. PubMed ID: 22734423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroretentive drug delivery system of DA-6034, a new flavonoid derivative, for the treatment of gastritis.
    Jang SW; Lee JW; Park SH; Kim JH; Yoo M; Na DH; Lee KC
    Int J Pharm; 2008 May; 356(1-2):88-94. PubMed ID: 18276090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research on preparation of Shandantong sustained-release tablets].
    Yuan WP; Liu LN; Wang M
    Zhong Yao Cai; 2008 Oct; 31(10):1564-7. PubMed ID: 19230418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the preparation of rapid-dissoluted EGb droppills].
    Ge YB; Chen DW; Li ZB; Ma Y; Song HX; Hu HY
    Zhongguo Zhong Yao Za Zhi; 2003 May; 28(5):410-3. PubMed ID: 15139123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formulation optimization of controlled porosity osmotic-pump tablets of total paeony glycosides].
    Zhang H; Wang WP
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2185-7. PubMed ID: 19166002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Breviscapine Toward Serum Albumin Studied by Spectroscopic and Electrochemical Techniques.
    Liu W; Chen Y; Chen H; Zhang Y
    J Biochem Mol Toxicol; 2016 Sep; 30(9):447-54. PubMed ID: 27080000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
    Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
    Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized preparation, characterization and biodistribution in heart of breviscapine lipid emulsion.
    Xiong F; Wang H; Geng KK; Gu N; Zhu JB
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1455-60. PubMed ID: 21048336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.